DNA integrity and transgene expression after passage through the NOGA needle catheter used for therapeutic myocardial angiogenesis

Abstract

BACKGROUND: The NOGA (Biosense Webster, Markham, ON, Canada) injection catheter is an innovative navigational device that provides an ideal platform for intra-myocardial injection material. However, injection through a long (1.91 m), narrow (27G) nitinol needle could result in deterioration in integrity and functionality of DNA. METHODS: To test this possibility, DNA in plasmid form (pcDNA3.1) containing the Lac Z transgene (250 µl) was passed through the NOGA needle using a handheld 1 cc syringe at a gentle hand injection pressure (43 &#45 3 PSI, 3.0 &#45 0.2 kg/cm 2 ) or at maximal manual pressure (90 &#45 6 PSI, 6.3 &#45 0.4 kg/cm 2 ), either once or 20 times. This DNA, compared to DNA not passed through the NOGA needle (control), was then used to transfect primary cultures of rat skin fibroblasts (FB) from Fisher 344 rats and the cells were subsequently stained for beta galactosidase ( &#103 gal). RESULTS: Transfection efficiency was significantly reduced by passing the DNA through the needle at both 43 &#45 3 PSI (78 &#45 4% of control, n = 10, P < 0.05 versus control) and 90 &#45 6 PSI (66 &#45 4 % of control, n = 10, P < 0.01 versus control, P < 0.02 versus 43 &#45 3 PSI). Passage of the DNA through the NOGA needle 20 times resulted in a transfection efficiency of only 5 &#45 1% of control ( n = 20, P < 0.1 X 10 -11 versus control). Capillary Electrophoresis revealed that the reduction in transfection efficiency was due to a conformational change in the DNA from predominantly supercoiled to nicked and linearized DNA. Transfection efficiency as compared with control decreased as the concentration of the DNA solution which was passed through the needle was increased from 0.3 µg/µl to 2.4 µg/µl. Recovery experiments confirmed that the reduction in transfection efficiency was not due to loss of DNA by binding to the NOGA needle. CONCLUSION: These results suggest that DNA is susceptible to shear forces when injected through the NOGA needle even at nominal clinical injection pressures, suggesting that careful and controlled injections will be required to achieve optimal gene integrity and expression. (Int J Cardiovasc Intervent 2000; 3: 167-172)

• Angiogenesis Catheter Dna Integrity Gene Therapy Myocardial Injection